Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Although GLP-1 agents are not first-line therapy for PCOS, they may benefit women with obesity who have not responded adequately to lifestyle interventions and metformin
D.EkhtiariH.BaldacchinoA
Obesity is a major risk factor for type 2 diabetes, cardiovascular diseases, and other comorbidities, creating a pressing need for therapeutic solutions that manage multiple conditions simultaneously
Rosenstock J, Wysham C, Fras JP, et al
36 Because appetite reduction is common with GLP-1 agonists, and many individuals on GLP-1 therapies are counseled to prioritize protein and/or follow a ketogenic diet to support muscle maintenance during weight loss, fiber intake is often reduced significantly as fruits, vegetables and grains are eliminated
US$ 26.24
US$ 26.50
US$ 26.55
US$ 27.59
US$ 21.75
US$ 23.11
